Two Sigma Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-193,891
| Closed | -$25.6M | – | 3675 |
|
|
2025
Q1 | $25.6M | Buy |
193,891
+51,100
| +36% | +$6.37M | 0.05% | 404 |
|
|
2024
Q4 | $11.9M | Buy |
142,791
+119,301
| +508% | +$9.8M | 0.03% | 675 |
|
|
2024
Q3 | $1.72M | Buy |
+23,490
| New | +$1.77M | ﹤0.01% | 1766 |
|
|
2022
Q1 | – | Sell |
-277,359
| Closed | -$14.5M | – | 4578 |
|
|
2021
Q4 | $14.5M | Buy |
+277,359
| New | +$11.7M | 0.03% | 607 |
|
|
2021
Q2 | – | Sell |
-10,587
| Closed | -$359K | – | 4669 |
|
|
2021
Q1 | $359K | Buy |
+10,587
| New | +$367K | ﹤0.01% | 3201 |
|
|
2020
Q2 | – | Sell |
-55,926
| Closed | -$860K | – | 3630 |
|
|
2020
Q1 | $860K | Buy |
55,926
+27,246
| +95% | +$592K | 0.01% | 1529 |
|
|
2019
Q4 | $984K | Sell |
28,680
-170,340
| -86% | -$2.04M | ﹤0.01% | 2193 |
|
|
2019
Q3 | $1.49M | Sell |
199,020
-27,673
| -12% | -$265K | 0.01% | 1656 |
|
|
2019
Q2 | $2.94M | Sell |
226,693
-64,641
| -22% | -$829K | 0.01% | 1199 |
|
|
2019
Q1 | $3.55M | Buy |
291,334
+98,681
| +51% | +$1.26M | 0.01% | 1141 |
|
|
2018
Q4 | $2.19M | Buy |
+192,653
| New | +$3.11M | 0.01% | 1196 |
|
|
2018
Q2 | – | Sell |
-96,274
| Closed | -$2.03M | – | 3736 |
|
|
2018
Q1 | $2.03M | Sell |
96,274
-60,800
| -39% | -$1.18M | 0.01% | 1511 |
|
|
2017
Q4 | $2.27M | Buy |
+157,074
| New | +$2.43M | 0.01% | 1375 |
|
|
2015
Q2 | – | Sell |
-20,947
| Closed | -$500K | – | 3154 |
|
|
2015
Q1 | $500K | Buy |
+20,947
| New | +$469K | ﹤0.01% | 1970 |
|
Other funds holding ITCI
KIM
HNB